Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cytovance Biologics Inc.

Division of Shenzhen Hepalink Pharmaceutical Co. Ltd.
www.cytovance.com

Latest From Cytovance Biologics Inc.

Appointments: Merck KGaA, Myovant, Scholar Rock, C4X Discovery, Paragon Bioservices and Gamida Cell.

This week's roundup includes appointments by Merck KGaA, C4X Discovery Holdings, Paragon Bioservices and board appointments by Scholar Rock, Myovant Sciences and Gamida Cell.

Appointments BioPharmaceutical

Execs On The Move, November 2016

Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Leadership BioPharmaceutical

Curb Your Enthusiasm: Chinese Pharmas Going Global Hit Speed Bumps

Ambitious and confident Chinese pharmaceutical buyers have begun to enter a new brave world of foreign M&A. However, this scenario can be littered with internal challenges and increasingly external scrutiny, less solid pre-deal asset identification and poor post-deal execution, all of which can damage their barely gained credibility, creating hurdles for future deals.

Deals M & A

Hepalink Strengthens Biologics Presence With OncoVent JV

China's Shenzhen Hepalink, a public company that claims to be one of the largest makers of heparin in the world, is aiming to build up its R&D activities for biologics through a newly formed Chinese JV with OncoQuest, which will leverage the two companies’ expertise and assets to develop novel cancer immunotherapies.

BioPharmaceutical China
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Shenzhen Hepalink Pharmaceutical Co. Ltd.
  • Senior Management
  • Yan Wang, PhD, CEO
    Matt Hamilton, VP, Fin.
    Lonnie Barish, VP, Bus. Dev. & Mktg.
    Jesse McCool, PhD, SVP, R&D Services & CTO
  • Contact Info
  • Cytovance Biologics Inc.
    Phone: (405) 319-8310
    800 Research Pkwy
    Ste 200
    Oklahoma City, OK 73104
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register